Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review
Caohang Qiu(Affiliated Hospital of Southwest Medical University), Lilei Peng(Southwest Medical University), Ning Sun(Ningbo College of Health Sciences), Shan Zeng(Central South University), Ligang Chen, Feilong Gong(Affiliated Hospital of Southwest Medical University), Junjie Tian(Affiliated Hospital of Southwest Medical University), Yu Xiong(State Key Laboratory of Oncogene and Related Genes), Haiping He(Affiliated Hospital of Southwest Medical University)
Cited by 6
Related Papers
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice
|Hepatology|2004|177
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
|Molecular Cancer|2025|98
ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells
|Journal of Cancer|2017|58
Heavy metals in daily meals and food ingredients in the Yangtze River Delta and their probabilistic health risk assessment
|The Science of The Total Environment|2022|54